Cargando…
Implications for Combination Therapy of Selective Monoamine Reuptake Inhibitors on Dopamine Transporters
Monoamine transporters, including dopamine, norepinephrine, and serotonin transporters (DAT, NET, and SERT, respectively), are important therapeutic targets due to their essential roles in the brain. To overcome the slow action of selective monoamine reuptake inhibitors, dual- or triple-acting inhib...
Autores principales: | Ahn, Hyomin, Park, Kichul, Kim, Dongyoung, Chi, Sung-Gil, Choi, Kee-Hyun, Han, Seo-Jung, Song, Chiman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604324/ https://www.ncbi.nlm.nih.gov/pubmed/37893219 http://dx.doi.org/10.3390/biomedicines11102846 |
Ejemplares similares
-
Monoamine depletion by reuptake inhibitors
por: Hinz, Marty, et al.
Publicado: (2011) -
Monoamine Reuptake Inhibitors in Parkinson's Disease
por: Huot, Philippe, et al.
Publicado: (2015) -
Monoamine Depletion by Reuptake Inhibitors [Retraction]
Publicado: (2020) -
Monoamine Depletion by Reuptake Inhibitors [Expression of Concern]
Publicado: (2020) -
Chirality Matters: Fine-Tuning of Novel Monoamine Reuptake Inhibitors Selectivity through Manipulation of Stereochemistry
por: Kalaba, Predrag, et al.
Publicado: (2023)